JCR Pharmaceuticals Co., Ltd.
JCRRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $13 | $13 | $16 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $13 | $12 | $15 |
| Inventory | $23 | $23 | $22 | $24 |
| Other Curr. Assets | -$23 | $3 | $4 | $3 |
| Total Curr. Assets | $0 | $53 | $51 | $58 |
| Property Plant & Equip (Net) | $37 | $37 | $37 | $32 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $3 | $3 | $3 |
| Long-Term Investments | $0 | $11 | $10 | $12 |
| Tax Assets | $0 | $0 | $3 | $0 |
| Other NC Assets | -$37 | $4 | $0 | $1 |
| Total NC Assets | $0 | $55 | $54 | $48 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1 | $107 | $105 | $106 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $1 | $1 |
| Short-Term Debt | $0 | $28 | $26 | $20 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $16 | $14 | $17 |
| Total Curr. Liab. | $0 | $47 | $44 | $39 |
| LT Debt | $0 | $12 | $12 | $12 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $1 | $1 | $1 |
| Total NC Liab. | $0 | $13 | $13 | $13 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $0 | $61 | $57 | $53 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $9 | $9 | $9 |
| Retained Earnings | $0 | $29 | $31 | $35 |
| AOCI | $0 | $2 | $1 | $3 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $0 | $46 | $47 | $53 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1 | $107 | $104 | $106 |
| Net Debt | $0 | $27 | $25 | $17 |